Health Advantage TPros prostate treatment claims draw FDA warning letter.
This article was originally published in The Tan Sheet
Executive Summary
HEALTH ADVANTAGE TPROS BPH TREATMENT CLAIMS DRAW WARNING LETTER from FDA dated Jan. 17 admonishing the company for suggesting that Dr. Mutter's TPros caplets (formerly PRos Care) are useful in treating and/or preventing benign prostatic hypertrophy and its symptoms. One claim highlighted by the agency states: "This unique combination of all-natural elements, Serenoa repens, Pygeum Africanum, zinc picolinate, vitamin B6 and nettle root extract works to relieve the nagging symptoms of an enlarged prostate...as well as contribute to improved sexual performance."
You may also be interested in...
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
In Brief
Combe sells most of its OTC brands
People In Brief
Perrigo promotes in pricing, planning